paediatrics Brussels 17

• n = 47 recurrences (1. RT 54-59.4 Gy) • 29 x OP+CTX vs. 18 x reRT (50.4 – 59.4 Gy +/- CSA) +/-OP • No higher grade acute toxicity • 7 vs 81% OS after 3 yrs. - / + reRT • Late adverse events: endocrine dysfunction, neurocognitive issues